AMOTL2 and neoplasm: In PC, hypoxic exosome-mediated UCA1 could promote tumor angiogenesis and accelerate tumor growth via the miR-96-5P/AMOTL2/ERK1/2 axis and serve as a novel therapeutic target (Guo et al., 2020).